Nasal vaccine not for those who've already taken booster dose: India vaccine task force head

Updated : Dec 30, 2022 06:52
|
Editorji News Desk

Bharat Biotech's iNCOVACC, the nasal vaccine recently approved by the Indian government, cannot be taken as a second booster dose, according to an NDTV report.

The needle-less vaccine is recommended as the first booster, and not meant for those who have already taken a precaution dose, the report quoted Dr NK Arora, head of India's vaccine task force, as saying.

He added that "at the moment", taking a fourth dose of vaccine is of "no value", and this option is also not available on the vaccination app CoWIN.

"Let us assume you want to take another fourth dose. There is a concept what is called as 'antigen sink'. If a person is repeatedly immunised with a particular type of antigen, the body stops responding, or responds poorly.

And that is why initially mRNA vaccines are given with a gap of six months. Later on, people are taking at three-month gap. But it has not helped too much in that case. Therefore, at the moment taking a fourth dose is of no value," Dr Arora said.

Also read|India nasal vaccine price: ₹800 at private, ₹325 in govt hospitals, GST extra for Bharat Biotech iNCOVACC

Nasal VaccineBharat BiotechIndiacovidincovacc

Recommended For You

editorji | India

CBI arrests key accused in murder of Suvendu Adhikari's aide from UP

editorji | India

CBI arrests Latur-based coaching centre founder in NEET-UG paper leak case

editorji | India

ED arrests AAP's Deepak Singla after raids in 'bank fraud' case; party calls it political vendetta

editorji | India

Suvendu govt ends religion-based aid, sets up panels to probe corruption, crimes against women during TMC

editorji | India

Friends, relatives protest at Jantar Mantra seeking CBI probe into Twisha Sharma’s death